Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03884309 · ClinicalTrials.gov registry record · NA
Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula
A NA study of Protein Intolerance, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 6
- Study locations
NCT03884309 is a NA study of Protein Intolerance that has completed, run by Abbott Nutrition. The registered enrollment target is 48 participants. The trial reports 6 study locations across 5 states.
The verdict
NCT03884309, a NA study of Protein Intolerance, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a single group, non-randomized, multicenter study to assess the effects of a hypoallergenic casein hydrolysate powdered infant formula on gastrointestinal (GI) tolerance, growth and compliance in an intended use infant population.
Conditions Studied
Interventions
- OTHER Experimental Hydrolyzed Protein Infant Formula
Study Locations (6)
Texas
- Ventavia Research Group, LLC - Houston
- DCOL Center for Clinical Research - Longview
Georgia
- Paramount Research Solutions - College Park
Kentucky
- Michael W. Simon, M.D., PSC - Nicholasville
Nebraska
- Midwest Children's Health Research Institute - Lincoln
Tennessee
- Memphis & Shelby County Pediatric Group - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2019-03-25 |
| Est. Completion | 2020-01-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03884309
The ClinicalTrials.gov registry entry for NCT03884309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Protein Intolerance appearing as the primary indexed condition, and to 1 intervention - of which Experimental Hydrolyzed Protein Infant Formula is the first listed.
NCT03884309 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Texas, Georgia, Kentucky.
Frequently Asked Questions
What is clinical trial NCT03884309 about?
NCT03884309 is a clinical study titled "Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula". This is a single group, non-randomized, multicenter study to assess the effects of a hypoallergenic casein hydrolysate powdered infant formula on gastrointestinal (GI) tolerance, growth and compliance in an intended use infant population.
What is the current status of trial NCT03884309?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2019-03-25. Estimated completion is 2020-01-07.
What conditions does trial NCT03884309 study?
This clinical trial studies the following conditions: Protein Intolerance.
What interventions are being tested in trial NCT03884309?
The interventions under investigation include: Experimental Hydrolyzed Protein Infant Formula (OTHER).
Who is sponsoring clinical trial NCT03884309?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03884309 being conducted?
This trial has 6 study locations across Georgia, Kentucky, Nebraska, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.